Literature DB >> 6861707

Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma.

M D Snavely, L C Mahan, D T O'Connor, P A Insel.   

Abstract

We have used an animal model of pheochromocytoma and radioligand-binding techniques to examine the effects of high levels of circulating norepinephrine and dopamine on adrenergic receptor subtypes in several peripheral tissues. New England Deaconess Hospital rats with transplanted pheochromocytomas were hypertensive and had levels of plasma norepinephrine and dopamine 50-fold greater than those of controls. The number of beta-adrenergic receptors in membranes prepared from the renal cortex and the left ventricle from these rats was decreased about 50%, but the animals had no significant decrease in the overall number of beta-adrenergic receptors in pulmonary membranes. beta-Receptor affinity was unaltered in animals with pheochromocytoma. Competition for [125I]iodocyanopindolol binding to beta-receptors by subtype-selective agents indicated a selective decrease of about 80% in the number of beta 1-adrenergic receptors in renal cortical and pulmonary membranes, without a decrease in beta 2-adrenergic receptor number. Rats with pheochromocytoma also had about a 70% decrease in the number of alpha 1-adrenergic receptors in membranes from renal cortex and lung, but no significant decrease in the number of alpha 1-adrenergic receptors in hepatic membranes and no decrease in the number of alpha 2-adrenergic receptors in renal cortical and hepatic membranes. These results indicate that rats in which pheochromocytomas are transplanted show adrenergic receptor subtype- and tissue-specific down-regulation. Although the selective down-regulation of alpha 1- and beta 1-adrenergic receptors may reflect a response to the preponderance of norepinephrine in these animals, the results indicate that different tissues and different adrenergic receptor subtypes may have varying susceptibility to down-regulation in response to increased circulating catecholamines in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861707     DOI: 10.1210/endo-113-1-354

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Diagnosis and treatment of extra-adrenal pheochromocytoma of urinary bladder: case report and literature review.

Authors:  Wei Li; Bin Yang; Jian-Ping Che; Yang Yan; Min Liu; Qian-Yu Li; Yuan-Yuan Zhang; Jun-Hua Zheng
Journal:  Int J Clin Exp Med       Date:  2013-09-25

Review 2.  Platelet alpha-adrenoceptors--a valid model for brain or vascular adrenoceptors?

Authors:  C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

3.  Alpha 1-adrenoceptors of rat myocardium: comparison of agonist binding and positive inotropic response.

Authors:  G Gross; G Hanft; C U Rugevics
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

4.  Rapid desensitization of neonatal rat liver beta-adrenergic receptors. A role for beta-adrenergic receptor kinase.

Authors:  I García-Higuera; F Mayor
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

5.  Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system.

Authors:  G Tsujimoto; K Hashimoto; B B Hoffman
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

6.  Differential regulation of right and left ventricular beta-adrenergic receptors in newborn lambs with experimental cyanotic heart disease.

Authors:  D Bernstein; E Voss; S Huang; R Doshi; C Crane
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 7.  Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.

Authors:  Guido Grassi; Fosca Quarti Trevano; Raffaella Dell'Oro; Gino Seravalle; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

8.  Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit.

Authors:  N M Deighton; A D Brown; C A Hamilton; J L Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

9.  Contrasting action of short- and long-term adrenaline infusion on dog skeletal muscle glucose metabolism.

Authors:  M J Christopher; M W Sleeman; F P Alford; J D Best
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

10.  Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy.

Authors:  N Makino; H Matsui; K Masutomo; T Hata; T Yanaga
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.